Osteopontin and other regulators of angiogenesis and fibrogenesis in the vitreous from patients with proliferative vitreoretinal disorders.
The aim of this study was to determine the levels of the angiogenic and fibrogenic factors osteopontin (OPN), high-mobility group box-1 (HMGB1), and connective tissue growth factor (CTGF) and the antiangiogenic and antifibrogenic pigment epithelium-derived factor (PEDF) in the vitreous fluid from patients with proliferative diabetic retinopathy (PDR), proliferative vitreoretinopathy (PVR), and rhegmatogenous retinal detachment with no PVR (RD). Vitreous samples from 48 PDR, 17 PVR and 30 RD patients were studied by enzyme-linked immunosorbent assay. OPN, HMGB1, CTGF, and PEDF levels were significantly higher in PDR patients than in RD patients (P < 0.001; 0.002; <0.001; <0.001, resp.). CTGF and PEDF levels were significantly higher in PVR patients than in RD patients (P < 0.001; 0.004, resp.). Exploratory logistic regression analysis identified significant associations between PDR and high levels of HMGB1, CTGF and PEDF, between PDR with active neovascularization and high levels of CTGF and PEDF, and between PDR with traction retinal detachment and high levels of HMGB1. In patients with PDR, there were significant correlations between the levels of PEDF and the levels of OPN (r = 0.544, P = 0.001), HMGB1 (r = 0.719, P < 0.001), and CTGF (r = 0.715, P < 0.001). In patients with PVR, there were significant correlations between the levels of OPN and the levels of HMGB1 (r = 0.484, P = 0.049) and PEDF (r = 0.559, P = 0.02). Our findings suggest that OPN, HMGB1, and CTGF contribute to the pathogenesis of proliferative vitreoretinal disorders and that increased levels of PEDF may be a response to counterbalance the activity of angiogenic and fibrogenic factors in PDR and PVR.
Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.abuasrar@ksu.edu.sa
Ahmed M
AM
Abu El-Asrar
Mohd
M
Imtiaz Nawaz
Dustan
D
Kangave
Mohammed Mairaj
MM
Siddiquei
Karel
K
Geboes
D055513:Connective Tissue Growth Factor / Q000378:metabolism; D005136:Eye Proteins / Q000378:metabolism; D024243:HMGB1 Protein / Q000378:metabolism; D006801:Humans; D009389:Neovascularization, Pathologic / Q000378:metabolism*; D009414:Nerve Growth Factors / Q000378:metabolism; D053495:Osteopontin / Q000378:metabolism*; D015843:Serpins / Q000378:metabolism; D018630:Vitreoretinopathy, Proliferative / Q000378:metabolism*; D014822:Vitreous Body / Q000378:metabolism; D000099174:Pigment Epithelium-Derived Factor
D055513:Connective Tissue Growth Factor; D005136:Eye Proteins; D024243:HMGB1 Protein; D009414:Nerve Growth Factors; D053495:Osteopontin; D015843:Serpins; D000099174:Pigment Epithelium-Derived Factor; C526317:CCN2 protein, human